Amgen Inc. Collaboration Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
2017
Second Amendment to Collaboration Agreement, entered into as of February 26, 2023, by and between Amgen Inc. and BeiGene Switzerland GmbH, and BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
2023
First Amendment to Collaboration Agreement, dated April 20, 2022, by and between Amgen Inc. and BeiGene Switzerland GmbH, and BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
Biotechnology
2022
Amendment No. 8 to the Collaboration Agreement, dated November 19, 2021, by and between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2022
Amendment No. 3 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG (portions of the exhibit have been...
Collaboration Agreements
Amgen Inc.
Biotechnology
2022
Amended and Restated Collaboration Agreement, dated June 2, 2021, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2021
Amendment No. 7 to the Collaboration Agreement, dated December 18, 2020, by and between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2021
Amendment No. 2 to the Collaboration Agreement, dated August 19, 2020, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
2020
Amendment Nos. 2 through 6 to the March 30, 2012 Collaboration Agreement between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC, dated May 2 and 27 and October 2, 2016,...
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2020
Side Letter Regarding Collaboration Agreement and Stivarga Agreement, dated February 13, 2020, by and between Onyx Pharmaceuticals, Inc. and Bayer HealthCare LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
2020
Collaboration Agreement, dated October 31, 2019, by and between Amgen Inc. and BeiGene Switzerland GmbH, a wholly-owned subsidiary of BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2020
Amendment No. 1 to the Collaboration Agreement, dated March 20, 2018, by and between Novartis Pharma AG and Amgen Inc. (portions of the exhibit have been omitted pursuant to a...
Collaboration Agreements
Amgen Inc.
Biotechnology
2018
Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2017
Amendment No. 2 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
2017
Exclusive License and Collaboration Agreement, dated August 28, 2015, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2017
Collaboration Agreement By and Between Amgen Inc. and Daiichi Sankyo Company, Limited
Collaboration Agreements
Amgen Inc.
Biotechnology
DE
2007